From Aurora Imaging Technology, Inc.;
The Aurora® 1.5T Dedicated Breast MRI System with Bilateral SpiralRODEO™ is the first and only FDA approved MRI device designed specifically for breast imaging. The Aurora System, which is already in clinical use at a growing number of leading breast care centers in the US, Europe, got in December 2006 also the approval from the State Food and Drug Administration of the People's Republic of China (SFDA).
'Some of the proprietary and distinguishing features of the Aurora System include: 1) an ellipsoid magnetic shim that provides coverage of both breasts, the chest wall and bilateral axillary lymph nodes; 2) a precision gradient coil with the high linearity required for high resolution spiral reconstruction;; 3) a patient-handling table that provides patient comfort and procedural utility; 4) a fully integrated Interventional System for MRI guided biopsy and localization; and 5) the user-friendly AuroraCAD™ computer-aided image display system designed to improve the accuracy and efficiency of diagnostic interpretations.'

(MRI-CA, MRCA) The noninvasive imaging of the coronary arteries using magnetic resonance imaging of the heart.
For cardiac MRI-CA, high performance machines are necessary with minimum 40mT/m and 300μsec slew rate.
2D and 3D acquisition are used for fast gradient echo sequences with techniques for minimizing cardiac and respiratory motion and suppressing the high signal of pericardial fat. The optimal sequences seem to be trueFISP, Balanced FFE or FIESTA with SMASH and SENSE techniques. Respiratory motion is minimized for 3D acquisitions by using respiratory gating, especially using navigator echoes (Navigator Technique) to track diaphragmatic and cardiac movement. Optimization of MR technique can provide mapping of long segments of the coronary arteries.
Blood pool agents are being applied to improve the reliability of coronary MR angiography. The major current clinical indication is the identification of coronary artery anomalies because the diagnostic accuracy's for identifying haemodynamically significant stenoses are variable depending of the image quality.

See also Magnetic Resonance Angiography, and Cardiac MRI.

Quick Overview

Ghosting artifacts are in the most cases caused by movements (e.g., respiratory motion, bowel motion, arterial pulsations, swallowing, and heartbeat) and appear in the phase encoding direction.

Ghosting artifacts can be reduced by respiratory and cardiac triggering, the use of breath holding pulse sequences, flow compensation or presaturation pulses, depending on their origin. To reduce bowel motion also pharmaceuticals, such as glucagon or scopolamine are useful. This will decrease artifacts from both peristalsis and breathing.

See also Motion Artifact, Phase Encoded Motion Artifact, Cardiac Motion Artifact, and Artifact Reduction - Motion.

(PEAR) Each phase of the respiratory cycle coincides with the collection of phase encoded data. The low order phase encoded data, with is highly sensitive to motion, is collected towards the end of exhalation and beginning of inspiration. The high order data, which is less sensitive, is collected over the remaining part of each respiratory cycle.

Quick Overview

Fat suppression (SPIR or FatSat) is very critical to the magnetic field homogeneity. Eddy currents in the patient results in B1 disturbance from left to right and from anterior to posterior. The artifact is seen as signal intensity variations with SPIR, like a signal intensity loss diagonal in the image. The short T1 inversion recovery (STIR) sequence is due to another type of fat suppression insensitive to this artifact.

Take short T1 inversion recovery (STIR) instead spectral presaturation inversion recovery (SPIR) for fat suppression.